Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
Autism spectrum disorders (ASD) affect 1% of children. Although there is no cure, early diagnosis and behavioral intervention can relieve the symptoms. The clinical heterogeneity of ASD has created a need for improved sensitive and specific laboratory diagnostic methods. Liquid chromatography-tandem...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fncel.2019.00007/full |
_version_ | 1819364767483035648 |
---|---|
author | Aiping Liu Wei Zhou Liuhong Qu Fusheng He Hui Wang Yan Wang Chunquan Cai Xiaoge Li Wenhao Zhou Mingbang Wang |
author_facet | Aiping Liu Wei Zhou Liuhong Qu Fusheng He Hui Wang Yan Wang Chunquan Cai Xiaoge Li Wenhao Zhou Mingbang Wang |
author_sort | Aiping Liu |
collection | DOAJ |
description | Autism spectrum disorders (ASD) affect 1% of children. Although there is no cure, early diagnosis and behavioral intervention can relieve the symptoms. The clinical heterogeneity of ASD has created a need for improved sensitive and specific laboratory diagnostic methods. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based analysis of the metabolome has shown great potential to uncover biomarkers for complex diseases such as ASD. Here, we used a two-step discovery–validation approach to identify potential novel metabolic biomarkers for ASD. Urine samples from 57 children with ASD and 81 matched children with typical development (TD) were analyzed by LS-MS/MS to assess differences in urinary amino acids and their metabolites (referred to as UAA indicators). A total of 63 UAA indicators were identified, of which 21 were present at significantly different levels in the urine of ASD children compared with TD children. Of these 21, the concentrations of 19 and 10 were higher and lower, respectively, in the urine of ASD children compared with TD children. Using support vector machine modeling and receiver operating characteristic curve analysis, we identified a panel of 7 UAA indicators that discriminated between the samples from ASD and TD children (lysine, 2-aminoisobutyric acid, 5-hydroxytryptamine, proline, aspartate, arginine/ornithine, and 4-hydroxyproline). Among the significantly changed pathways in ASD children were the ornithine/urea cycle (decreased levels of the excitatory amino acid aspartate [p = 2.15 × 10-10] and increased arginine/ornithine [p = 5.21 × 10-9]), tryptophan metabolism (increased levels of inhibitory 5-hydroxytryptamine p = 3.62 × 10-9), the methionine cycle (increased methionine sulfoxide [p = 1.46 × 10-10] and decreased homocysteine [p = 2.73 × 10-7]), and lysine metabolism (reduced lysine [p = 7.8 × 10-9], α-aminoadipic acid [p = 1.16 × 10-9], and 5-aminovaleric acid [p = 1.05 × 10-5]). Collectively, the data presented here identify a possible imbalance between excitatory and inhibitory amino acid metabolism in ASD children. The significantly altered UAA indicators could therefore be potential diagnostic biomarkers for ASD. |
first_indexed | 2024-12-24T23:04:10Z |
format | Article |
id | doaj.art-b89590d01ee14ecd810ac3e4fa6533d6 |
institution | Directory Open Access Journal |
issn | 1662-5102 |
language | English |
last_indexed | 2024-12-24T23:04:10Z |
publishDate | 2019-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cellular Neuroscience |
spelling | doaj.art-b89590d01ee14ecd810ac3e4fa6533d62022-12-21T16:35:03ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022019-01-011310.3389/fncel.2019.00007408936Altered Urinary Amino Acids in Children With Autism Spectrum DisordersAiping Liu0Wei Zhou1Liuhong Qu2Fusheng He3Hui Wang4Yan Wang5Chunquan Cai6Xiaoge Li7Wenhao Zhou8Mingbang Wang9Shiyan Prevention and Health Care Center of Shenzhen, Shenzhen, ChinaDivision of Neonatology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, ChinaDivision of Neonatology, The Maternal and Child Health Care Hospital of Huadu District, Huadu Affiliated Hospital of Guangdong Medical University, Guangzhou, ChinaImunobio, Shenzhen, ChinaXiamen Branch of Children’s Hospital of Fudan University (Xiamen Children’s Hospital), Xiamen, ChinaDivision of Neonatology, The Maternal and Child Health Care Hospital of Huadu District, Huadu Affiliated Hospital of Guangdong Medical University, Guangzhou, ChinaDivision of Neurosurgery, Tianjin Children’s Hospital, Tianjin, ChinaTianjin Jinnan Xiaozhan Hospital, Tianjin, ChinaShanghai Key Laboratory of Birth Defects, Division of Neonatology, Children’s Hospital of Fudan University, National Center for Children’s Health, Shanghai, ChinaShanghai Key Laboratory of Birth Defects, Division of Neonatology, Xiamen Branch of Children’s Hospital of Fudan University (Xiamen Children’s Hospital), Children’s Hospital of Fudan University, National Center for Children’s Health, Shanghai, ChinaAutism spectrum disorders (ASD) affect 1% of children. Although there is no cure, early diagnosis and behavioral intervention can relieve the symptoms. The clinical heterogeneity of ASD has created a need for improved sensitive and specific laboratory diagnostic methods. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based analysis of the metabolome has shown great potential to uncover biomarkers for complex diseases such as ASD. Here, we used a two-step discovery–validation approach to identify potential novel metabolic biomarkers for ASD. Urine samples from 57 children with ASD and 81 matched children with typical development (TD) were analyzed by LS-MS/MS to assess differences in urinary amino acids and their metabolites (referred to as UAA indicators). A total of 63 UAA indicators were identified, of which 21 were present at significantly different levels in the urine of ASD children compared with TD children. Of these 21, the concentrations of 19 and 10 were higher and lower, respectively, in the urine of ASD children compared with TD children. Using support vector machine modeling and receiver operating characteristic curve analysis, we identified a panel of 7 UAA indicators that discriminated between the samples from ASD and TD children (lysine, 2-aminoisobutyric acid, 5-hydroxytryptamine, proline, aspartate, arginine/ornithine, and 4-hydroxyproline). Among the significantly changed pathways in ASD children were the ornithine/urea cycle (decreased levels of the excitatory amino acid aspartate [p = 2.15 × 10-10] and increased arginine/ornithine [p = 5.21 × 10-9]), tryptophan metabolism (increased levels of inhibitory 5-hydroxytryptamine p = 3.62 × 10-9), the methionine cycle (increased methionine sulfoxide [p = 1.46 × 10-10] and decreased homocysteine [p = 2.73 × 10-7]), and lysine metabolism (reduced lysine [p = 7.8 × 10-9], α-aminoadipic acid [p = 1.16 × 10-9], and 5-aminovaleric acid [p = 1.05 × 10-5]). Collectively, the data presented here identify a possible imbalance between excitatory and inhibitory amino acid metabolism in ASD children. The significantly altered UAA indicators could therefore be potential diagnostic biomarkers for ASD.https://www.frontiersin.org/article/10.3389/fncel.2019.00007/fullASDurinary amino acidsmetabolomeLC-MS/MSchildren |
spellingShingle | Aiping Liu Wei Zhou Liuhong Qu Fusheng He Hui Wang Yan Wang Chunquan Cai Xiaoge Li Wenhao Zhou Mingbang Wang Altered Urinary Amino Acids in Children With Autism Spectrum Disorders Frontiers in Cellular Neuroscience ASD urinary amino acids metabolome LC-MS/MS children |
title | Altered Urinary Amino Acids in Children With Autism Spectrum Disorders |
title_full | Altered Urinary Amino Acids in Children With Autism Spectrum Disorders |
title_fullStr | Altered Urinary Amino Acids in Children With Autism Spectrum Disorders |
title_full_unstemmed | Altered Urinary Amino Acids in Children With Autism Spectrum Disorders |
title_short | Altered Urinary Amino Acids in Children With Autism Spectrum Disorders |
title_sort | altered urinary amino acids in children with autism spectrum disorders |
topic | ASD urinary amino acids metabolome LC-MS/MS children |
url | https://www.frontiersin.org/article/10.3389/fncel.2019.00007/full |
work_keys_str_mv | AT aipingliu alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT weizhou alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT liuhongqu alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT fushenghe alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT huiwang alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT yanwang alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT chunquancai alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT xiaogeli alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT wenhaozhou alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders AT mingbangwang alteredurinaryaminoacidsinchildrenwithautismspectrumdisorders |